Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on June 25, 2026

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
BrewDog Inverurie Reopens with New Community Champions Model
Young workers willing to make career trade-offs for jobs with pensions: new research from HOOPP and Abacus Data
New CAOT project to support internationally educated OTs in Canada
Un nouveau projet de l’ACE pour soutenir les ergothérapeutes diplômés à l’étranger au Canada
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets
Maple Tree Counselling Brings Culturally Attuned Therapy to Central Hong Kong as HK's Professionals, Families, and Expats Face Rising Emotional Pressure
EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis
Press Release: Sanofi Foundation opens new chapter centered on future generations
Communiqué de presse : La Fondation Sanofi ouvre un nouveau chapitre centré sur les générations futures
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.